9.750% Senior Secured Notes due 2034
Note · CHS/Community Health Systems, Inc.
Reference: 9.750% Senior Secured Notes due 2034
- Original principal
- USD 1,790,000,000
- Outstanding
- —
- Commitment
- —
- Availability
- —
- Maturity
- Jan 15, 2034
Last reported interest terms: 9.75% Reported 2025-08-12 Later filings may not restate these terms; this does not confirm they still apply.
Verified covenant terms
-
(i) · a Default or an Event of Default shall have occurred and be continuing
a Default or an Event of Default shall have occurred and be continuing (or would result immediately thereafter therefrom);
Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
Full wording and supporting evidence
Source evidence: (i) a Default or an Event of Default shall have occurred and be continuing (or would result immediately thereafter therefrom);
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(17) · Restricted Payments (including loans or advances) in an aggregate amount
does not exceed the greater of $375,000,000 and 3.0% of Total Assets
Applies to every series under this agreement Metric: aggregate amount
Stated threshold: 375000000 $
SECTION 3.3. Limitation on Restricted Payments.
Full wording and supporting evidence
Source evidence: (17) Restricted Payments (including loans or advances) in an aggregate amount which, when taken together with all Restricted Payments previously made pursuant to this clause (17), does not exceed the greater of $375,000,000 and 3.0% of Total Assets; *provided, however*, that, at the time of each such Restricted Payment, no Default or Event of Default shall have occurred and be continuing (or result therefrom);
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(18) · the Consolidated Total Leverage Ratio would be no greater than 3.50 to 1.00
the Consolidated Total Leverage Ratio would be no greater than 3.50 to 1.00
Applies to every series under this agreement Metric: Consolidated Total Leverage Ratio
Stated threshold: 3.5 to 1.00
SECTION 3.3. Limitation on Restricted Payments.
Full wording and supporting evidence
Source evidence: (18) any Restricted Payment made by the Issuer or any Restricted Subsidiary; *provided* that, immediately after giving pro forma effect thereto and the Incurrence of any Indebtedness the net proceeds of which are used to finance such Restricted Payment, the Consolidated Total Leverage Ratio would be no greater than 3.50 to 1.00; and
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(ii) · the Issuer is not able to Incur an additional $1.00 of Indebtedness
the Issuer is not able to Incur an additional $1.00 of Indebtedness pursuant to Section 3.2(a) after giving effect, on a pro forma basis, to such Restricted Payment; or
Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
Full wording and supporting evidence
Source evidence: (ii) the Issuer is not able to Incur an additional $1.00 of Indebtedness pursuant to Section 3.2(a) after giving effect, on a pro forma basis, to such Restricted Payment; or
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(a) · The Issuer shall not, and shall not permit any of its Restricted Subsidiaries
The Issuer shall not, and shall not permit any of its Restricted Subsidiaries, directly or indirectly, to:
Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
Full wording and supporting evidence
Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries, directly or indirectly, to:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(iii) · the aggregate amount of such Restricted Payment and all other Restricted Payments made since the RP Reference Date
would exceed the sum of (without duplication):
Applies to every series under this agreement SECTION 3.3. Limitation on Restricted Payments.
Full wording and supporting evidence
Source evidence: (iii) the aggregate amount of such Restricted Payment and all other Restricted Payments made since the RP Reference Date (and not returned or rescinded) (including Permitted Payments made pursuant to Section 3.3(b)(1) (without duplication), but excluding all other Restricted Payments permitted by Section 3.3(b)) would exceed the sum of (without duplication):
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
SECTION 2.1. · may not issue any Additional Notes
the Issuer may not issue any Additional Notes, unless such issuance is in compliance with this Indenture, including Sections 3.2 and 3.6.
Applies to every series under this agreement SECTION 2.1. Form, Dating and Terms.
Full wording and supporting evidence
Source evidence: Notwithstanding anything to the contrary contained herein, the Issuer may not issue any Additional Notes, unless such issuance is in compliance with this Indenture, including Sections 3.2 and 3.6.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 3.2(a) · Limitation on Indebtedness
The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, Incur any Indebtedness (including Acquired Indebtedness)
Applies to every series under this agreement Metric: Fixed Charge Coverage Ratio
Stated threshold: 2 to 1.00
Testing frequency: on the date of such Incurrence SECTION 3.2. Limitation on Indebtedness.
Full wording and supporting evidence
Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, Incur any Indebtedness (including Acquired Indebtedness); *provided*, *however*, that the Issuer and any of the Subsidiary Guarantors may Incur Indebtedness (including Acquired Indebtedness), if on the date of such Incurrence and after giving pro forma effect thereto (including pro forma application of the proceeds thereof), the Fixed Charge Coverage Ratio for the Issuer and its Restricted Subsidiaries is greater than 2.00 to 1.00.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 3.19(a) · Holdings and the Issuer shall not, and shall not permit
Holdings and the Issuer shall not, and shall not permit any Restricted Subsidiary to, take or knowingly or negligently omit to take, any action
Applies to every series under this agreement SECTION 3.19. Impairment of Security Interest.
Full wording and supporting evidence
Source evidence: (a) Holdings and the Issuer shall not, and shall not permit any Restricted Subsidiary to, take or knowingly or negligently omit to take, any action which action or omission might reasonably or would (in the good faith determination of the Issuer) have the result of materially impairing the effectiveness of the security interests
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 3.6(a) · Limitation on Liens
The Issuer shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create, Incur or permit to exist any Lien
Applies to every series under this agreement SECTION 3.6. Limitation on Liens.
Full wording and supporting evidence
Source evidence: (a) The Issuer shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create, Incur or permit to exist any Lien (the “Initial Lien”) on any of its assets or properties, in each case whether owned on the Issue Date or thereafter acquired, securing any Indebtedness, other than:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(a) · make any Asset Disposition unless
The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, make any Asset Disposition unless:
Applies to every series under this agreement SECTION 3.5. Limitation on Sales of Assets and Subsidiary Stock.
Full wording and supporting evidence
Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, make any Asset Disposition unless:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 3.5(b) · Asset Disposition Offer
the Issuer shall within twenty (20) Business Days be required to make an offer
Applies to every series under this agreement SECTION 3.5. Limitation on Sales of Assets and Subsidiary Stock.
Full wording and supporting evidence
Source evidence: (b) Any Net Available Cash from Asset Dispositions that is not applied or invested or committed to be applied or invested as provided in Section 3.5(a) shall be deemed to constitute “Excess Proceeds” under this Indenture. On the 451st day after an Asset Disposition or the receipt of such Net Available Cash, if the aggregate amount of Excess Proceeds under this Indenture exceeds $200,000,000, the Issuer shall within twenty (20) Business Days be required to make an offer (“Asset Disposition Offer”) to all Holders
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(b) · the Issuer shall within twenty (20) Business Days be required to make an offer
the Issuer shall within twenty (20) Business Days be required to make an offer
Applies to every series under this agreement Metric: aggregate amount of Excess Proceeds under this Indenture
Stated threshold: 200000000 $
SECTION 3.5. Limitation on Sales of Assets and Subsidiary Stock.
Full wording and supporting evidence
Source evidence: (b) Any Net Available Cash from Asset Dispositions that is not applied or invested or committed to be applied or invested as provided in Section 3.5(a) shall be deemed to constitute “Excess Proceeds” under this Indenture. On the 451st day after an Asset Disposition or the receipt of such Net Available Cash, if the aggregate amount of Excess Proceeds under this Indenture exceeds $200,000,000, the Issuer shall within twenty (20) Business Days be required to make an offer (“Asset Disposition Offer”) to all Holders and, to the extent the Issuer elects, to the holders of any other outstanding Senior-Priority Obligations (and only to the extent the Excess Proceeds are greater than the outstanding Senior-Priority Obligations, other Senior Indebtedness), to purchase the maximum principal amount of Notes, at an offer price equal to 100% of the principal amount of the Notes, and any such Senior-Priority Obligations (and, if applicable, Senior Indebtedness) to which the Asset Disposition Offer applies that may be purchased out of the Excess Proceeds, in each case, plus accrued and unpaid interest, if any, to, but not including, the date of purchase, in accordance with the procedures set forth in this Indenture or the agreements governing any such Senior-Priority Obligations (and, if applicable, Senior Indebtedness), as applicable, and, with respect to the Notes, in minimum denominations of $2,000 and in integral multiples of $1,000 in excess thereof.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
8. Repurchase Provisions · Upon certain Asset Dispositions
Upon certain Asset Dispositions, the Issuer may be required to use the Excess Proceeds from such Asset Dispositions to offer to purchase the maximum aggregate principal amount of Notes
Applies to every series under this agreement 8. Repurchase Provisions
Full wording and supporting evidence
Source evidence: Upon certain Asset Dispositions, the Issuer may be required to use the Excess Proceeds from such Asset Dispositions to offer to purchase the maximum aggregate principal amount of Notes and, at the Issuer’s option, Senior-Priority Obligations (and, only to the extent the Excess Proceeds are greater than the outstanding Senior-Priority Obligations, Senior Indebtedness) that may be purchased out of the Excess Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date fixed for the closing of such offer, in accordance with the procedures set forth in Section 3.5 and in Article V of the Indenture.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 4.1(e) · No Guarantor may:
No Guarantor may:
Applies to every series under this agreement SECTION 4.1. Merger and Consolidation.
Full wording and supporting evidence
Source evidence: (e) No Guarantor may:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 4.1(a) · The Issuer will not consolidate with or merge with or into or convey, transfer or lease all or substantially all its assets
The Issuer will not consolidate with or merge with or into or convey, transfer or lease all or substantially all its assets, in one or more related transactions, to any Person, unless:
Applies to every series under this agreement SECTION 4.1. Merger and Consolidation.
Full wording and supporting evidence
Source evidence: (a) The Issuer will not consolidate with or merge with or into or convey, transfer or lease all or substantially all its assets, in one or more related transactions, to any Person, unless:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
8. Repurchase Provisions · If a Change of Control occurs
each Holder will have the right to require the Issuer to repurchase from each Holder all or any part
Applies to every series under this agreement Exceptions: unless the Issuer has previously or concurrently delivered a redemption notice with respect to all outstanding Notes pursuant to Section 5.7 of the Indenture that is or has become unconditional 8. Repurchase Provisions
Full wording and supporting evidence
Source evidence: If a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with respect to all outstanding Notes pursuant to Section 5.7 of the Indenture that is or has become unconditional, each Holder will have the right to require the Issuer to repurchase from each Holder all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of such Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof plus accrued and unpaid interest, if any, to, but excluding, the date of purchase, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date as provided in, and subject to the terms of, the Indenture.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 3.9(a) · If a Change of Control occurs
the Issuer shall make an offer to purchase all of the Notes pursuant to the offer described below
Applies to every series under this agreement Exceptions: unless the Issuer has previously or concurrently delivered a redemption notice with respect to all the outstanding Notes as described under Section 5.7 SECTION 3.9. Change of Control.
Full wording and supporting evidence
Source evidence: (a) If a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with respect to all the outstanding Notes as described under Section 5.7 that is or has become unconditional and subject to Section 3.9(c) or under Article XI, the Issuer shall make an offer to purchase all of the Notes pursuant to the offer described below
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(f) · the Issuer may satisfy its obligations in this Section 3.10
the Issuer may satisfy its obligations in this Section 3.10 with respect to financial information relating to the Issuer by furnishing financial and other information relating to any Parent Entity instead of the Issuer;
Applies to every series under this agreement (f) Notwithstanding anything to the contrary set forth in this Section 3.10
Full wording and supporting evidence
Source evidence: (f) Notwithstanding anything to the contrary set forth in this Section 3.10, the Issuer may satisfy its obligations in this Section 3.10 with respect to financial information relating to the Issuer by furnishing financial and other information relating to any Parent Entity instead of the Issuer;
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
SECTION 3.14. · The Issuer shall deliver to the Trustee within 120 days after the end of each fiscal year of the Issuer
The Issuer shall deliver to the Trustee within 120 days after the end of each fiscal year of the Issuer
Applies to every series under this agreement SECTION 3.14. Compliance Certificate.
Full wording and supporting evidence
Source evidence: SECTION 3.14. Compliance Certificate. The Issuer shall deliver to the Trustee within 120 days after the end of each fiscal year of the Issuer (beginning with the fiscal year ending December 31, 2025) an Officer’s Certificate, signed by the Chief Executive Officer, Chief Financial Officer or the Treasurer of the Issuer,
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
SECTION 3.16. · The Issuer shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice
The Issuer shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice of any events of which it is aware which would constitute a Default or Event of Default
Applies to every series under this agreement SECTION 3.16. Statement by Officers as to Default.
Full wording and supporting evidence
Source evidence: SECTION 3.16. Statement by Officers as to Default. The Issuer shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice of any events of which it is aware which would constitute a Default or Event of Default, their status and what action the Issuer is taking or proposes to take in respect thereof.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(d) · The Issuer shall hold quarterly conference calls for the Holders
The Issuer shall hold quarterly conference calls for the Holders to discuss financial information for the previous quarter
Applies to every series under this agreement (d) The Issuer shall hold quarterly conference calls for the Holders
Full wording and supporting evidence
Source evidence: (d) The Issuer shall hold quarterly conference calls for the Holders to discuss financial information for the previous quarter (it being understood that such quarterly conference call may be the same conference call as with Holdings’ equity investors and analysts).
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 3.10(a) · Reports
the Issuer will furnish to the Trustee, within fifteen (15) days after the time periods specified below:
Applies to every series under this agreement SECTION 3.10. Reports.
Full wording and supporting evidence
Source evidence: (a) Whether or not required by the SEC, so long as any Notes are outstanding, if not filed electronically with the SEC through the SEC’s Electronic Data Gathering, Analysis, and Retrieval System (or any successor system), from and after the Issue Date, the Issuer will furnish to the Trustee, within fifteen (15) days after the time periods specified below:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(9) · any Note Guarantee ceases to be in full force and effect, other than in accordance with the terms of this Indenture
any Note Guarantee ceases to be in full force and effect, other than in accordance with the terms of this Indenture, or a Guarantor denies or disaffirms its obligations under its Note Guarantee
Applies to every series under this agreement Exceptions: upon release of such Note Guarantee in accordance with this Indenture SECTION 6.1. Events of Default.
Full wording and supporting evidence
Source evidence: (9) any Note Guarantee ceases to be in full force and effect, other than in accordance with the terms of this Indenture, or a Guarantor denies or disaffirms its obligations under its Note Guarantee, other than in accordance with the terms thereof or upon release of such Note Guarantee in accordance with this Indenture
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(5) · default under any mortgage, indenture or instrument
default under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries
Applies to every series under this agreement Exceptions: other than Indebtedness owed to the Issuer or a Restricted Subsidiary SECTION 6.1. Events of Default.
Full wording and supporting evidence
Source evidence: (5) default under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries (or the payment of which is Guaranteed by the Issuer or any of its Restricted Subsidiaries) other than Indebtedness owed to the Issuer or a Restricted Subsidiary whether such Indebtedness or Guarantee now exists, or is created after the Issue Date, which default:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(4) · failure by the Issuer or any Guarantor to comply for 60 days after written notice
failure by the Issuer or any Guarantor to comply for 60 days after written notice by the Trustee on behalf of the Holders or by the Holders of 30% in principal amount of the outstanding Notes with any other agreement or obligation
Applies to every series under this agreement Exceptions: no such notice may be given with respect to any action taken, and reported publicly or to the Holders, more than two years prior to such notice SECTION 6.1. Events of Default.
Full wording and supporting evidence
Source evidence: (4) failure by the Issuer or any Guarantor to comply for 60 days after written notice by the Trustee on behalf of the Holders or by the Holders of 30% in principal amount of the outstanding Notes with any other agreement or obligation contained in the Notes, this Indenture or the Notes Collateral Documents; *provided* that no such notice may be given with respect to any action taken, and reported publicly or to the Holders, more than two years prior to such notice;
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(8) · failure by the Issuer or any Significant Subsidiary
failure by the Issuer or any Significant Subsidiary (or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries) would constitute a Significant Subsidiary) to pay final judgments aggregating in excess of $150,000,000
Applies to every series under this agreement Metric: final judgments aggregating
Stated threshold: 150000000 $
Exceptions: other than any judgments covered by indemnities provided by, or insurance policies issued by, reputable and creditworthy companies SECTION 6.1. Events of Default.
Full wording and supporting evidence
Source evidence: (8) failure by the Issuer or any Significant Subsidiary (or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries) would constitute a Significant Subsidiary) to pay final judgments aggregating in excess of $150,000,000 (other than any judgments covered by indemnities provided by, or insurance policies issued by, reputable and creditworthy companies), which final judgments remain unpaid, undischarged and unstayed for a period of more than 60 days after such judgment becomes final,
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(3) · failure by the Issuer or Holdings to comply with its obligations under Article IV
failure by the Issuer or Holdings to comply with its obligations under Article IV;
Applies to every series under this agreement SECTION 6.1. Events of Default.
Full wording and supporting evidence
Source evidence: (3) failure by the Issuer or Holdings to comply with its obligations under Article IV;
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(6) · Holdings, the Issuer or a Significant Subsidiary or group
Holdings, the Issuer or a Significant Subsidiary or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law:
Applies to every series under this agreement SECTION 6.1. Events of Default.
Full wording and supporting evidence
Source evidence: (6) Holdings, the Issuer or a Significant Subsidiary or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
13. Defaults and Remedies · if an Event of Default
may declare the principal of and accrued and unpaid interest
Applies to every series under this agreement 13. Defaults and Remedies
Full wording and supporting evidence
Source evidence: Except as provided otherwise in the Indenture, if an Event of Default (other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Issuer or Holdings) occurs and is continuing, the Trustee by notice to the Issuer, or the Holders of at least 30% in principal amount of the outstanding Notes by notice to the Issuer and the Trustee, may declare the principal of and accrued and unpaid interest, if any, on all the Notes to be due and payable immediately.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
SECTION 12.5. Real Property Mortgage. · shall deliver to the Collateral Agent, within 270 days after the Issue Date
the Issuer shall deliver to the Collateral Agent, within 270 days after the Issue Date (or such longer period as the Collateral Agent may agree in its sole discretion)
SECTION 12.5. Real Property Mortgage.
Full wording and supporting evidence
Source evidence: SECTION 12.5. Real Property Mortgage. The Issuer will use its commercially reasonable efforts to complete or cause to be completed on or prior to the Issue Date all filings and other similar actions required or desirable on its part in connection with the creation, perfection, protection and/or reaffirmation of such security interests in favor of the Notes and the Note Guarantees. In the case of real property constituting Mortgaged Property, the Issuer shall deliver to the Collateral Agent, within 270 days after the Issue Date (or such longer period as the Collateral Agent may agree in its sole discretion): (a) counterparts of amended or amended and restated mortgages securing the Obligations with respect to the Notes and the Note Guarantees, duly executed and delivered by the Grantor that is the record owner of each applicable Mortgaged Property and otherwise suitable for recording and in form and substance sufficient to grant to the Collateral Agent for the benefit of the Senior-Priority Non-ABL Secured Parties a valid mortgage lien on such real property; (b) title searches confirming that there are no Liens of record in violation of the applicable mortgage; (c) modification and date down endorsements to the existing title insurance policies; provided, however, with respect to the Mortgaged Properties located in Texas, a title search and T-38 endorsement, to the extent available, and, with respect to Mortgaged Properties in New Mexico, a title search and a modification endorsement; and (d) local counsel opinions, and any other documents reasonably requested by the Collateral Agent in respect of the amended or amended and restated mortgages.
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
Target identity evidence: WHEREAS, the Issuer has duly authorized the execution and delivery of this Indenture to provide for the issuance of (i) $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Initial Notes”), each as issued on the date hereof and (ii) any additional Notes that may be issued after the Issue Date in compliance with this Indenture (the “Additional Notes” and together with the Initial Notes, the “Notes”);
-
Section 3.8(a) · Limitation on Affiliate Transactions
The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, enter into or conduct any transaction
Applies to every series under this agreement Metric: aggregate value
Stated threshold: 40000000 $
SECTION 3.8. Limitation on Affiliate Transactions.
Full wording and supporting evidence
Source evidence: (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, enter into or conduct any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of the Issuer (an “Affiliate Transaction”) involving aggregate value in excess of $40,000,000 unless:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
(a) · create or otherwise cause or permit to exist or become effective any consensual encumbrance or consensual restriction
The Issuer shall not, and shall not permit any Restricted Subsidiary that is not a Guarantor to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or consensual restriction
Applies to every series under this agreement SECTION 3.4. Limitation on Restrictions on Distributions from Restricted Subsidiaries.
Full wording and supporting evidence
Source evidence: (a) The Issuer shall not, and shall not permit any Restricted Subsidiary that is not a Guarantor to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or consensual restriction on the ability of any Restricted Subsidiary that is not a Guarantor to:
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
SECTION 3.13. · The Issuer shall pay or discharge or cause to be paid or discharged, before the same shall become delinquent, all material taxes
The Issuer shall pay or discharge or cause to be paid or discharged, before the same shall become delinquent, all material taxes, assessments and governmental charges levied or imposed upon the Issuer or any Subsidiary;
Applies to every series under this agreement SECTION 3.13. Payment of Taxes.
Full wording and supporting evidence
Source evidence: SECTION 3.13. Payment of Taxes. The Issuer shall pay or discharge or cause to be paid or discharged, before the same shall become delinquent, all material taxes, assessments and governmental charges levied or imposed upon the Issuer or any Subsidiary;
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
SECTION 3.12. · the Issuer will do or cause to be done all things necessary
the Issuer will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence
Applies to every series under this agreement SECTION 3.12. Corporate Existence.
Full wording and supporting evidence
Source evidence: SECTION 3.12. Corporate Existence. Except as otherwise provided in this Article III, Article IV and Section 10.2(b), the Issuer will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
-
Section 3.7(a) · Limitation on Guarantees
The Issuer will not permit any of its Wholly Owned Domestic Subsidiaries that are Restricted Subsidiaries
Applies to every series under this agreement SECTION 3.7. Limitation on Guarantees.
Full wording and supporting evidence
Source evidence: (a) The Issuer will not permit any of its Wholly Owned Domestic Subsidiaries that are Restricted Subsidiaries
Target identity evidence: INDENTURE dated as of August 12, 2025, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Guarantors party hereto from time to time and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee and collateral agent.
Documents and filing history
- SeriesInstrument · EX-4.1 · 2025-08-12 — EX-4.1
- GoverningAgreement · EX-4.1 · 2025-08-12 — EX-4.1
- GoverningAgreement · EX-4.1 · 2025-08-12 — EX-4.1
- Issuance · 8-K · 2025-08-12 — 8-K
-
Issuance
· 2025-08-12
Original principal USD 1,790,000,000 Exact source document
Parent 8-K filing · 2025-08-12
WHEREAS, each of the Issuer, the Guarantors, the Trustee and the Collateral Agent have heretofore executed and delivered an indenture dated as of August 12, 2025 (as amended, supplemented, waived or otherwise modified, the “Indenture”), providing for the issuance on such date of an aggregate principal amount of $1,790,000,000 of 9.750% Senior Secured Notes due 2034 (the “Notes”) of the Issuer;
Issuer evidence: SUPPLEMENTAL INDENTURE, (this “Supplemental Indenture”) dated as of [ ], 20[ ], by and among CHS/Community Health Systems, Inc., a Delaware corporation (“Issuer”), the parties that are signatories hereto as Guarantors (each, a “Guaranteeing Subsidiary”) and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent under the Indenture referred to below.
Supporting evidence: WHEREAS, each of the Issuer, the Guarantors, the Trustee and the Collateral Agent have heretofore executed and delivered an indenture dated as of August 12, 2025 (as amended, supplemented, waived or otherwise modified, the “Indenture”), providing for the issuance on such date of an aggregate principal amount of $1,790,000,000 of 9.750% Senior Secured Notes due 2034 (the “Notes”) of the Issuer;
-
Issuance
· 2025-08-12
Original principal USD 1,790,000,000 Exact source document
Parent 8-K filing · 2025-08-12
On August 12, 2025, CHS/Community Health Systems, Inc. (the “Issuer”), a direct, wholly owned subsidiary of Community Health Systems, Inc. (the “Company”), completed its previously announced offering (the “Notes Offering”) of $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Notes”). The terms of the Notes are governed by an indenture, dated as of August 12, 2025, among the Issuer, the Company, the subsidiary guarantors party thereto, U.S. Bank Trust Company, National Association, as trustee and as collateral agent (the “Collateral Agent”) (the “Indenture”).
Issuer evidence: On August 12, 2025, CHS/Community Health Systems, Inc. (the “Issuer”), a direct, wholly owned subsidiary of Community Health Systems, Inc. (the “Company”), completed its previously announced offering (the “Notes Offering”) of $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Notes”). The terms of the Notes are governed by an indenture, dated as of August 12, 2025, among the Issuer, the Company, the subsidiary guarantors party thereto, U.S. Bank Trust Company, National Association, as trustee and as collateral agent (the “Collateral Agent”) (the “Indenture”).
Supporting evidence: The Notes bear interest at a rate of 9.750% per year payable semi-annually in arrears on March 15 and September 15 of each year (and January 15, 2034, the maturity date), commencing on March 15, 2026.
Supporting evidence: On August 12, 2025, CHS/Community Health Systems, Inc. (the “Issuer”), a direct, wholly owned subsidiary of Community Health Systems, Inc. (the “Company”), completed its previously announced offering (the “Notes Offering”) of $1,790,000,000 aggregate principal amount of its 9.750% Senior Secured Notes due 2034 (the “Notes”). The terms of the Notes are governed by an indenture, dated as of August 12, 2025, among the Issuer, the Company, the subsidiary guarantors party thereto, U.S. Bank Trust Company, National Association, as trustee and as collateral agent (the “Collateral Agent”) (the “Indenture”).